Evidence map›Paper›PMID 29304840›Full record

ArticleJournal of health, population, and nutrition2018

Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study.

Frezghi Hidray Gebreweld, Meron Mehari Kifle, Fitusm Eyob Gebremicheal, Leban Lebahati Simel, Meron Mebrahtu Gezae, Shewit Sibhatu Ghebreyesus, Yordanos Tesfamariam Mengsteab, Nebiat Ghirmay Wahd

Open access · goldAbstract read
In one paragraph

Article in Journal of health, population, and nutrition, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 2 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 2 syntheses or guidelines pooled it, 182 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Frezghi Hidray GebreweldMinistry of Health, Asmara, Eritrea.
Meron Mehari KifleDepartment of Epidemiology and Biostatistics, School of Public Health, Asmara College of Health Sciences, Asmara, Eritrea. meronmehari121@gmail.com.
Fitusm Eyob GebremichealMinistry of Health, Asmara, Eritrea.
Leban Lebahati SimelDepartment of Epidemiology and Biostatistics, School of Public Health, Asmara College of Health Sciences, Asmara, Eritrea.
Meron Mebrahtu GezaeMinistry of Health, Asmara, Eritrea.
Shewit Sibhatu GhebreyesusMinistry of Health, Asmara, Eritrea.
Yordanos Tesfamariam MengsteabMinistry of Health, Asmara, Eritrea.
Nebiat Ghirmay WahdMinistry of Health, Asmara, Eritrea.
University of Asmara · ER

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-adherence to tuberculosis (TB) treatment is an important barrier for TB prevention and control. Poor adherence may result in prolonged disease infectiousness, drug resistance, relapse and death. The aim of this study was to assess factors influencing adherence to tuberculosis treatment in selected health facilities in Asmara, Eritrea.

methodsA qualitative study which included in-depth interviews with 12 TB patients, three focus group discussions in selected health facilities in which one group comprised eight patients and key informant interviews with three health workers. Data analysis was done by translating and transcribing the verbatim of the interviews and focus group discussions. Transcribed data was then analysed using thematic framework procedure.

resultsThis study found that patients lacked knowledge about the cause, transmission and duration of treatment of TB. The most common reason mentioned for discontinuing treatment was the patient "felt cured". Almost half of the respondents did not know the standard treatment duration and the consequences they face if they halt treatment. Patients reported losing their job when their diagnosis was known, were too ill to continue working or unable to find daily work due to time-consuming treatment arrangements. With few exceptions, the majority of patients reported that the short distance to the clinic encouraged them to attend regular treatment follow-up. Most of the respondents were unable to get enough food, leading to stress and feelings of hopelessness. Lack of social support for most of the patients was a critical factor for adherence as were stigma, medication side effects and long treatment duration. Recognized as an enabler to treatment adherence, health workers had good communication and positive attitude towards their patients.

conclusionLack of knowledge, loss of income, stigma and lack of social support, drug side effects and long treatment duration emerged as important barriers for treatment adherence. Short distances to health facilities, good communication and accepting attitude of health care providers emerged as enablers for treatment adherence. For better treatment adherence, comprehensive health education at treatment sites, patient's family members and the community at large and strengthening of social support structures need to be addressed.

Indexed as

Drug-Related Side Effects and Adverse ReactionsEmploymentHealth Knowledge, Attitudes, PracticeMedication AdherenceSocial SupportAdolescentAdultAmbulatory Care FacilitiesAntitubercular AgentsEritreaFemaleFocus GroupsHealth EducationHealth PersonnelHumansIncomeAntitubercular AgentsAsmaraBarriers to treatment adherenceDOTSEritreaTuberculosis

Identifiers

PMID29304840
PMCPMC5756387
OpenAlexW2782275118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.